(IFM) myeloma: a phase 2 study of the Intergroupe Francophone du Myélome autologous stem cell transplantation in patients with de novo multiple Bortezomib and high-dose melphalan as conditioning regimen before
2013
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
45
References
0
Citations
NaN
KQI